Agios Pharmaceuticals Inc Marge brute
Quel est le Marge brute de Agios Pharmaceuticals Inc?
Le Marge brute de Agios Pharmaceuticals Inc est 89.26%
Quelle est la définition de Marge brute?
La marge brute est la différence entre le revenu et le coût des biens vendus, divisée par le revenu et exprimée en pourcentage.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Marge brute des entreprises dans Health Care secteur sur NASDAQ par rapport à Agios Pharmaceuticals Inc
Que fait Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Entreprises avec marge brute similaire à Agios Pharmaceuticals Inc
- Darktrace plc a Marge brute de 89.21%
- Proactis Plc a Marge brute de 89.23%
- Tian An Australia a Marge brute de 89.23%
- Bajaj Finance a Marge brute de 89.24%
- Nirlon a Marge brute de 89.25%
- Ackroo a Marge brute de 89.26%
- Agios Pharmaceuticals Inc a Marge brute de 89.26%
- UroGen Pharma a Marge brute de 89.27%
- SREI Infrastructure Finance a Marge brute de 89.29%
- KemPharm a Marge brute de 89.29%
- Beijing Baolande Software a Marge brute de 89.31%
- BF Utilities a Marge brute de 89.33%
- Doximity a Marge brute de 89.34%